Lead Indirect Procurement Fresher's job

Job Summary:

The Indirect procurement sourcing lead will lead the sourcing of sub-categories of Engg-MRO, CAPEX, Admin. Consumables, Laboratory consumables and Services. He/She will be responsible for the following.

• Conduct Rigorous Spend Analytics of each sub-category to establish Roadmap of Strategic Sourcing
• Define category strategy identifying the key levers to maximize savings through structured Ideation for MRO, Capex, Admin., Lab & Service expenses
• Guide individual category buyers to establish the structure and management for Procurement Excellence
• Work with category stakeholders and business partners to strengthen procurement policies and procedures
• Compliance to Audits, both Internal and External
• Measure and track performance KPI's of each spend category and define budgetary impact

Academic Background and Experience

• Should be Engineering Graduate in any discipline with MBA.
• 8 years of experience & would have handled teams.
• Experience with SAP and e-procurement tools.
• Strong Business & Finance acumen.

Key performance Indicators:

• Building of sustainable procurement strategies.
• Improved Operational excellence.
• Audit Compliances.

Key personal attributes:

• Should have good communication & interpersonal relationships.
• Result Orientation
• Ability to work with cross functional teams
• Should have analytical and problem solving ability

Apply Link- Apply link mentioned in below

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.[2] Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. In 2014, Dr. Reddy Laboratories was listed among 1200 of India's most trusted brands according to the Brand Trust Report 2014, a study conducted by Trust Research Advisory, a brand analytics company.[3]
By 2007, Dr. Reddy's had seven FDA plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications five of them in India and two in the UK.[4]